Pear Bio
Latest round
- Series A
Last raised
- May 2023
Total raised
- $14M
Investors
- 1
About Pear Bio
Based in Canterbury, UK, and founded in 2017, Ourotech Ltd, trading under the name Pear Bio provides chips that visualize and compute cancer tumors. The company offers microtumor technology which recreates the core part of the human tumor microenvironment and provides accurate lab testing. The firm’s technology utilizes organ-on-chip and computer vision which combines 3D cell culture, functional testing, computer vision, and multi-omics analysis and model the spread of cancer as well as assess drug impacts on its progression.
Who invested in Pear Bio
1 investor across 1 round
See all investors in Pear Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 15, 2023
Amount
$14M
Investors
Questions about Pear Bio
Who invested in Pear Bio?
Pear Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pear Bio raised?
Pear Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pear Bio last raise money?
Pear Bio's most recent round on record is a Series A, in May 2023.
What does Pear Bio do?
Based in Canterbury, UK, and founded in 2017, Ourotech Ltd, trading under the name Pear Bio provides chips that visualize and compute cancer tumors.
Where is Pear Bio headquartered?
Pear Bio is headquartered in Canterbury, UK.
Which VCs invest in companies like Pear Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Pear Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pear Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.